izokibep
izokibep: developed by 1 company · 3 clinical trials tracked.
izokibep evidence translation
What we can confirm
3 tracked trials
What it means
What to watch
Prepared research question
How could izokibep → SLRN affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence3 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Development Pipeline (1)
| Company | Phase |
|---|---|
| ACELYRIN, Inc. (SLRN) Hidradenitis Suppurativa; Psoriatic Arthritis | Phase 3 |
Clinical Trials (3)
A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Izokibep in Subjects With Moderate to Severe Hidradenitis Suppurativa
Primary endpoint: Percentage of Participants Achieving Hidradenitis Suppurativa Clinical Response 75 (HiSCR75) at Week 12
A Randomized, Double-blind, Placebo-controlled, Multicenter Phase 2b/3 Study to Evaluate the Efficacy and Safety of Izokibep in Subjects With Active Psoriatic Arthritis
Primary endpoint: Number of Participants Who Achieved 50% Improvement in American College of Rheumatology (ACR50) at Week 16
A Phase 2b Study to Evaluate the Efficacy and Safety of Izokibep in Subjects With Moderate to Severe Hidradenitis Suppurativa
Primary endpoint: Part A: Number of Participants Who Achieved Hidradenitis Suppurativa Clinical Response 75 (HiSCR75) at Week 12
Frequently asked questions
Who is developing izokibep?
izokibep is being developed by ACELYRIN, Inc..
How many clinical trials involve izokibep?
BioSniper tracks 3 clinical trials involving izokibep.